VIKING THERAPEUTICS INC (VKTX)
US92686J1060 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 36.60M | 26.40M | 29.10M | |||
| Cash Equivalents | 195.58M | 55.52M | N/A | N/A | N/A | |||
| Marketable Securities | 767.40M | 306.56M | 118.90M | 175.70M | 219.30M | |||
| Other Current Assets | 3.36M | 5.15M | 11.60M | 8.40M | 7.70M | |||
| Total Current Assets | 966.34M | 367.23M | 167.00M | 210.50M | 256.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.05M | 1.13M | 1.40M | 0.00 | 300.00K | |||
| Other Non-Current Assets | 131.00K | 139.00K | 100.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 1.18M | 1.26M | 1.50M | 200.00K | 400.00K | |||
| TOTAL ASSETS | 967.52M | 368.49M | 168.50M | 210.70M | 256.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 27.55M | 11.62M | 13.40M | 7.30M | 8.10M | |||
| Accounts Payable | 5.22M | 7.51M | 8.50M | 1.40M | 4.00M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 32.77M | 19.14M | 21.90M | 8.80M | 12.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 852.00K | 936.00K | 1.30M | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 852.00K | 936.00K | 1.30M | 0.00 | 100.00K | |||
| TOTAL LIABILITIES | 33.63M | 20.07M | 23.20M | 8.80M | 12.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -405.30M | -377.94M | -292.00M | -223.20M | -168.20M | |||
| Additional Paid In Capital | 1.34B | 733.55M | 445.30M | 425.60M | 412.60M | |||
| Common Shares | 1.00K | 1.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | 0.00 | -6.79M | -6.80M | N/A | N/A | |||
| Other Shareholders' Equity | -1.60M | -389.00K | -1.10M | -500.00K | -100.00K | |||
| Shares Outstanding | 110.23M | 100.11M | 78.30M | 78.20M | 73.20M | |||
| Tangible Book Value per Share | 8.47 | 3.48 | 1.86 | 2.58 | 3.34 | |||
| Total Shareholders' Equity | 933.89M | 348.42M | 145.30M | 201.90M | 244.30M | |||
| TOTAL LIABILITIES AND EQUITY | 967.52M | 368.49M | 168.50M | 210.70M | 256.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 29.48 | 19.19 | 7.63 | 23.92 | 21.17 | |||
| Return On Assets (ROA) | -9.69% | -23.31% | -40.87% | -26.10% | -15.40% | |||
| Return On Equity (ROE) | -10.04% | -24.65% | -47.40% | -27.24% | -16.17% | |||
All data in USD